Dr Agarwal's Eye (526783)
Fast GrowerFairStock Score: 46/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹3,381.8 |
| Market Cap | ₹1,630 Cr |
| P/E Ratio | 31.83 |
| ROCE | 17.53% |
| ROE | 37.95% |
| Dividend Yield | 0.13% |
| Profit Growth | 66.15% |
| Debt/Equity | — |
| Sales Growth | 22.2% |
| 52-Week Range | ₹4,412.05 — ₹6,392 |
| Sector | Healthcare Services |
| Book Value | ₹391.49 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let's look at Dr Agarwal's Eye as a business, not a ticker. It earns a ROE of 37.95%, which is excellent; a 22% sales advance and a 66% profit jump show real momentum. The F-score of 7 out of 9 confirms a healthy financial picture. A leading eye-care franchise in India has a tangible moat—customers trust their eyes to a specialised brand, and repeat procedures make this a decent compounding machine.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer